KRAS and adenomyosis: Although no mutation candidates in ARID1A, TP53, or PTEN were validated as somatic mutations in adenomyosis (Supplementary Data 11), this TDS analysis revealed recurrent somatic pathogenic mutations of KRAS and PIK3CA in this disease (Supplementary Data 12).